FOLD Q4 2022 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M+7.2% YoY

Gross Profit

$79M89.3% margin

Operating Income

-$42M-48.0% margin

Net Income

-$56M-63.4% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$83M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$724M

Total Liabilities

$601M

Stockholders' Equity

$123M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$82M	+7.2%
Gross Profit	$79M	$74M	+5.9%
Operating Income	-$42M	-$72M	+41.3%
Net Income	-$56M	-$83M	+32.9%

Geographic Segments

Non-US

$54M61%

UNITED STATES

$34M39%